2012
October 11, 2017
|By Natasa Lagou
- Kapetral® (Capecitabine) was registered successfully in Cyprus.
- Remedica launches Quetra® (an anti-epileptic product containing Levetiracetam as the active ingredient).
- An ambitious program of product development was initiated that includes both block-busters as well as products for more targeted therapies.
- Late in the year, Remedica’s new oncology factory (Building No. 10) successfully passed a GMP inspection from the Cyprus Health Authorities.